A surgeon-scientist explores exosome-mediated stem cell engraftment as a means to lessen disease severity and enhance quality of life for children with hemoglobinopathies.
As we approach the end of 2016, for good or ill, this time of year lends itself to reflection. To look back over these 12 months in research at Children's Hospital of Philadelphia, we've decided to pick 12 of the most popular stories we've brought you in the past year. While any year has its hardships and its triumphs, we're
It has been a whirlwind week for most Americans, so if you need to break away from political news to catch up with your science news, you've come to the right place. This installment of In the News starts with an important study for patients with rare primary immunodeficiency diseases at risk of side effects from the rubella vaccine. Next,
The Children’s Hospital of Philadelphia’s John P. Dormans, MD, FACS, was recently elected to the presidency of the Scoliosis Research Society’s board of directors.
A recent grant from the Department of Defense (DoD) to The Children’s Hospital of Philadelphia will fund a new study of advanced transplantation techniques. The study, which is being led by Children’s Hospital’s Wayne Hancock, MBBS, PhD, FRCPA, will focus on vascularized composite allotransplantation (VCA), a type of transplantation in which multiple tissues — such as an entire hand — are transplanted “as a functional unit,” according to the American Society of Transplantation (AST). In particular, Dr. Hancock and his team will be working to develop “new approaches to immunosuppression,” he said.
After a closely contested race for votes between The Children's Hospital of Philadelphia and several other children's hospitals, CHOP's Center for Fetal Diagnosis and Treatment was recently awarded a $10,000 grant by CHERUBS, the Congenital Diaphragmatic Hernia Research Awareness and Support Advocacy Organization.
Advance the quality and scope of your research with easy access to state-of-the-art flow cytometers and professional services at the Flow Cytometry Core Laboratory.
